| 2024-04-29 23:48 | CC:AQS | Aequus Pharmaceuticals Inc | 0.015 | News Release200 | Aequus loses $2.96-million in 2023 |
| 2024-04-29 09:47 | CC:AQS | Aequus Pharmaceuticals Inc | 0.015 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-04-29 09:40 | CC:AQS | Aequus Pharmaceuticals Inc | 0.015 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-02-23 21:06 | CC:AQS | Aequus Pharmaceuticals Inc | 0.015 | News Release200 | Aequus Pharmaceuticals secures $285,410 loan |
| 2023-11-29 21:53 | CC:AQS | Aequus Pharmaceuticals Inc | 0.03 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-29 21:42 | CC:AQS | Aequus Pharmaceuticals Inc | 0.03 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-11-29 20:10 | CC:AQS | Aequus Pharmaceuticals Inc | 0.03 | News Release200 | Aequus Pharmaceuticals loses $803,653 in Q3 |
| 2023-10-20 17:12 | CC:AQS | Aequus Pharmaceuticals Inc | 0.03 | News Release200 | Aequus Pharmaceuticals takes $1-million loan from CEO |
| 2023-10-07 02:42 | CC:AQS | Aequus Pharmaceuticals Inc | 0.03 | News Release200 | Aequus obtains $270,000 loan from CEO Janzen |
| 2023-08-29 23:54 | CC:AQS | Aequus Pharmaceuticals Inc | 0.04 | News Release200 | Aequus loses $700,875 in Q2 |
| 2023-08-29 21:33 | CC:AQS | Aequus Pharmaceuticals Inc | 0.04 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-29 21:07 | CC:AQS | Aequus Pharmaceuticals Inc | 0.04 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-24 12:47 | CC:AQS | Aequus Pharmaceuticals Inc | 0.04 | News Release200 | Aequus Pharmaceuticals rolls out Zimed PF in Canada |
| 2023-08-18 09:28 | CC:AQS | Aequus Pharmaceuticals Inc | 0.04 | News Release200 | Aequus pauses sales of Evolve products in Canada |
| 2023-07-06 19:30 | CC:AQS | Aequus Pharmaceuticals Inc | 0.05 | News Release200 | Aequus increases debt by $400,000 |
| 2023-05-30 21:15 | CC:AQS | Aequus Pharmaceuticals Inc | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-30 21:15 | CC:AQS | Aequus Pharmaceuticals Inc | 0.025 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-30 20:31 | CC:AQS | Aequus Pharmaceuticals Inc | 0.025 | News Release200 | Aequus loses $744,323 in Q1 |